Genetic intervention is now a rational therapy for cancer, both to treat established malignancy and to reduce risk in predisposed individuals. Somatic gene therapy can be grouped into tumour suppressor gene replacement, oncogene blockade, genetic immunomodulation, genetic prodrug activation and polynucleotide vaccination. Each of these approaches has potential applications in pancreatic cancer, and this tumour type may be a suitable model for clinical trial.